MPPED2

Chr 11

metallophosphoesterase domain containing 2

Also known as: 239FB, C11orf8

Predicted to enable cyclic-nucleotide phosphodiesterase activity; manganese ion binding activity; and purine ribonucleotide binding activity. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
7
Pubs (1 yr)
P/LP submissions
P/LP missense
0.20
LOEUF· LoF intol.
Mechanism

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.20LOEUF
pLI 0.993
Z-score 3.59
OE 0.00 (0.000.20)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
2.00Z-score
OE missense 0.57 (0.480.68)
98 obs / 171.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.00 (0.000.20)
00.351.4
Missense OE?0.57 (0.480.68)
00.61.4
Synonymous OE?0.91
01.21.6
LoF obs/exp: 0 / 15.0Missense obs/exp: 98 / 171.5Syn Z: 0.60

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

MPPED2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →